Q32 Bio Inc.
QTTB
$15.15
-$0.22-1.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.72% | 31.02% | 506.86% | 58.01% | 44.11% |
| Total Depreciation and Amortization | -6.59% | -24.37% | -25.00% | -26.02% | -24.79% |
| Total Amortization of Deferred Charges | 31.25% | -31.25% | -24.49% | -8.00% | -172.73% |
| Total Other Non-Cash Items | -6.70% | 181.88% | -4,046.04% | 13.15% | 57.99% |
| Change in Net Operating Assets | 216.40% | 74.47% | -119.51% | 151.48% | 50.99% |
| Cash from Operations | 71.13% | 49.18% | 45.92% | 78.33% | 52.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 350,100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -117.94% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -592.74% | -256.77% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 621.26% | 119.66% | 93.32% | 32.51% | 40.32% |